Delivery Order SPE2DE24DA017-SPE2D625F1EZE
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $2,475 fixed-price delivery order on August 8, 2025, for the Arthrex ACP Double Syringe System. The contract, issued by the Defense Logistics Agency's Medical Supply Chain, carries an ultimate completion date of August 13, 2025, and represents a non-set-aside award. This delivery order falls under the company's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $5,775 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for the Arthrex ACP Double Syringe System. This delivery order, with an ultimate completion date of July 28, 2025, represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million...
- Arthrex Inc. has been awarded a delivery order valued at $16,500 for the Arthrex ACP Double Syringe System under a fixed-price contract with economic price adjustment provisions. The award, issued on August 1, 2025, with an ultimate completion date of August 6, 2025, was made by the Defense Logistics Agency's Medical Supply Chain to support federal healthcare requirements. The work will be performed in Naples, Florida, where Arthrex maintains its headquarters. This delivery order was not set...
- Arthrex Inc., a leading global orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a $8,664.00 fixed-price delivery order for the ARTHREX ACP Double Syringe System by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025. The delivery order, which carries an ultimate completion date of July 28, 2025, represents a task order against Arthrex's existing Indefinite Delivery Contract (SPE2DE24D0020) valued at $471,048,172.66 and running through...
- Arthrex Inc. was awarded a $4,950 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency's Medical Supply Chain on July 21, 2025, for the Arthrex ACP Double Syringe System, with an ultimate completion date of July 24, 2025. The award represents a non-set-aside contract and is being performed at Arthrex's Naples, Florida location. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $1,817.64 delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for an ACP MAX PRP (Autologous Conditioned Plasma Maximum Platelet-Rich Plasma) System with Autologous Conditioned Plasma technology. This fixed-price contract with economic price adjustment provisions is set to conclude by August 18, 2025, and represents a task order under Arthrex's larger Indefinite...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, received a $52,879.14 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, for an ACP MAX PRP System with ACDA technology. This delivery order represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) valued at $471 million and running through September 1, 2029. The contract carries no set-aside designation, reflecting Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $6,741.00 delivery order for an ACP Kit Series I from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025. This fixed-price delivery order with economic price adjustment is set to conclude on August 18, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) valued at $471,048,172.66 and running through September 1,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a $17,602.20 fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, for ARTHREX ACP DOUBLE 1S products. This delivery order, without set-aside designation, is expected to be completed by August 27, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC SPE2DE24D0020) with the Defense Logistics Agency,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,889.00 for an ACP Kit Series I on August 13, 2025, with a completion date of August 18, 2025. This fixed-price delivery order with economic price adjustment was issued through the Defense Logistics Agency's Medical Supply Chain, a defense-oriented federal agency supporting the Department of Defense and Department of Veterans Affairs healthcare systems. The...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F1EZEDelivery Order
Arthrex Inc., a leading developer and supplier of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, received a delivery order valued at $2,475 for the Arthrex ACP Double Syringe System from the Defense Logistics Agency's Medical Supply Chain division. This fixed-price delivery order with economic price adjustment capability was awarded on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract represents no set-aside designation, reflecting Arthrex's strong competitive position in the federal orthopedic medical device marketplace. Performance will be completed at the company's Naples, Florida facility. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and running through September 2029. That comprehensive IDC enables Veterans Affairs medical centers and Defense Department facilities nationwide to acquire Arthrex's full portfolio of orthopedic products, including surgical implants, arthroscopic instruments, and specialized surgical systems. The current delivery order for the ACP Double Syringe System—an autologous conditioned plasma delivery device used in orthopedic procedures—represents a routine task order under this established vehicle supporting government healthcare systems serving veterans and military personnel.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/18/25 |